Details for Patent: 4,879,303
✉ Email this page to a colleague
Summary for Patent: 4,879,303
| Title: | Pharmaceutically acceptable salts |
| Abstract: | Improved pharmaceutical salts of amlodipine, particularly the besylate salt, and pharmaceutical compositions thereof. These salts find utility as anti-ischaemic and anti-hypertensive agents. |
| Inventor(s): | Davison; Edward (Margate, GB2), Wells; James I. (Canterbury, GB2) |
| Assignee: | Pfizer Inc. (New York, NY) |
| Application Number: | 07/256,938 |
|
Patent Claim Types: see list of patent claims | Compound; Composition; Formulation; Dosage form; |
Drugs Protected by US Patent 4,879,303
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
Foreign Priority and PCT Information for Patent: 4,879,303
| Foriegn Application Priority Data | ||
| Foreign Country | Foreign Patent Number | Foreign Patent Date |
| United Kingdom | 8608335 | Apr 04, 1986 |
International Family Members for US Patent 4,879,303
| Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
|---|---|---|---|---|---|
| African Regional IP Organization (ARIPO) | 50 | ⤷ Sign Up | |||
| African Regional IP Organization (ARIPO) | 8700060 | ⤷ Sign Up | |||
| Argentina | 242562 | ⤷ Sign Up | |||
| Austria | 49752 | ⤷ Sign Up | |||
| Australia | 573123 | ⤷ Sign Up | |||
| Australia | 7103087 | ⤷ Sign Up | |||
| >Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |
